Terminal Illness: Clinical Trials

2 completed. 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	2	Completed 2

Follow Terminal Illness: new trials by email Literature Review of Terminal Illness trials Research Report on Terminal Illness

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Open-Label Treatment Extension of Protocol MNTX 302 SC Methylnaltrexone - Terminal Illness	Phase 3	Completed	Bausch Health Americas, Inc.	89	2004-03-01	2019-11-27
Open-Label Treatment Extension of Protocol MNTX 301 SC Methylnaltrexone (MNTX) - Terminal Illness	Phase 3	Completed	Bausch Health Americas, Inc.	27	2003-02-01	2019-11-27

Sponsors

Bausch Health Americas, Inc. (2)

Countries

United States (2)

Top investigators

Tage Ramakrishna, MD (2)